Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Ovarian Neoplasms 1Melanoma 1Kidney Neoplasms 1Childhood Cancer Survivors 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Dried Blood Spot Testing × Clear all
NCT07009288 2026-05-27

A Study of Time-Restricted Eating in Childhood Cancer Survivors

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
300 enrolled

Childhood Cancer Survivors

NCT04154163 2022-02-28

ADOPT

University of Dundee

Completed
18 enrolled
DermatologicGenitourinaryGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Melanoma, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡